An Indirect Treatment Comparison of Semaglutide 2.0 mg vs Dulaglutide 3.0 mg and 4.5 mg Using Multilevel Network Meta-regression

Overview

cited authors

Lingvay, Ildiko; Bauer, Robert; Baker-Knight, James; Lawson, Jack; Pratley, Richard

authors

Pratley, Richard Edwin, MD

Publication Date

December 18, 2021

webpage

Web of Science

published in

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM Journal

Research

keywords

HbA(1c)
body weight
diabetes
dulaglutide
multilevel network meta regression
semaglutide

301 E Princeton St., Orlando, FL 32804 | FH.RAS@AdventHealth.com | 407-200-2901

The information on this website is not a substitute for examination, diagnosis, and medical care provided by a licensed and qualified health professional. Please consult your physician before undertaking any form of medical treatment and/or adopting any exercise program or dietary guidelines. If you think you may have a medical emergency, call your physician or 911 immediately. AdventHealth Research Institute reserves the right to add, remove or edit content on this page at its sole discretion.